Jiangsu Huaxin New Material Co.,Ltd.

Jiangsu Huaxin New Material Co.,Ltd. is a company dedicated to the innovation, production, and sale of advanced functional film solutions. Their comprehensive product line features a variety of film types, including PETG, PVC, and PVC/ABS blends, as well as environmentally friendly bio-degradable PHA and specialized medical films. Beyond these, the company also supplies coated overlays, materials optimized for digital printing, robust PET and PC substrates for card manufacturing, specially coated PVC designed for antenna etching, and an extensive array of colored PVC items, including those with white coatings. These sophisticated materials find widespread application across numerous sectors, such as finance, transportation, telecommunications, interior design, packaging, healthcare, and social welfare programs. Founded in 1999, the firm operates from its main office located in Xinyi, China.

Jiangsu Huaxin New Material Co.,Ltd. trades as 300717.SZ on SHZ. The company is classified in Basic Materials / Chemicals - Specialty and reports in CNY.

The current profile places the business in Chemicals - Specialty. This section is intended to summarize the operating segments, products, geographies, and main revenue lines from official filings.

Detailed operating-segment data is not available for this symbol yet.

Use this area for management strategy, capital allocation priorities, target markets, and measurable goals from the latest annual report or investor presentation.

The app now provides the structure, but exact strategic claims should come from official company documents before being treated as a finished investment thesis.

Jiangsu Huaxin New Material Co.,Ltd. can be compared against peers such as Guangdong Decro Fi, Shanxi Tond Chemical Co., Ltd., Jiangxi Hengda Hi-Tech Co.,Ltd., Jiangsu Yuxing Film Technology Co., Ltd, Sichuan Dowell Science and Technology Inc., Zhuzhou Feilu High-Tech Materials Co., Ltd..

A complete thesis should compare growth, margins, balance-sheet risk, valuation multiples, and market position against direct competitors.

Current signals to investigate include market capitalization of $1.81B, beta of 0.43, and return on equity of N/A.

This section should be validated with evidence such as durable margins, brand strength, regulation, switching costs, cost advantage, distribution, or technology.

Key risks should include financial leverage, cyclicality, customer concentration, regulatory exposure, currency risk, and execution risk.

300717.SZ currently shows total debt of N/A and beta of 0.43. Missing data should be treated as a research gap, not as low risk.

Production-capacity detail is not available as structured data yet. For industrial, defense, semiconductor, or real-estate companies, this should be reviewed from annual reports and investor presentations.

No structured backlog field is available yet. If the company reports backlog, review the relevant filing section before adding it to the thesis.

Use this section for major contracts, product launches, construction projects, acquisitions, or strategic programs that can materially affect valuation.

No recent SEC-style filings are available for this symbol yet.

Customer concentration is not available as structured data here. Add it from official filings when a company discloses material customers or revenue concentration.

Supplier concentration and critical supply-chain dependencies are not available as structured data here. This should be researched from annual reports and risk disclosures.

Company website: https://www.huaxinchina.cc

For US-listed stocks, verify the thesis against official filings, earnings call transcripts, and company investor relations materials.